Altintas E et al. |
Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. |
2004 |
World J. Gastroenterol. |
pmid:15162544
|
Cosme A et al. |
Antimicrobial susceptibility testing before first-line treatment for infection in patients with dual or triple antibiotic resistance. |
2017 |
World J. Gastroenterol. |
pmid:28566898
|
Choi HS et al. |
Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection. |
2012 |
World J. Gastroenterol. |
pmid:22654429
|
Hagiwara T et al. |
Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection. |
2007 |
World J. Gastroenterol. |
pmid:17657838
|
Kawakami E et al. |
Furazolidone-based triple therapy for H pylori gastritis in children. |
2006 |
World J. Gastroenterol. |
pmid:17006997
|
Ahmad N et al. |
Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori. |
2009 |
World J. Gastroenterol. |
pmid:19575497
|
Miehlke S et al. |
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). |
2001 |
World J. Gastroenterol. |
pmid:11819768
|
Sun QJ et al. |
Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai. |
2010 |
World J. Gastroenterol. |
pmid:20976850
|
Chuah SK et al. |
A new look at anti-Helicobacter pylori therapy. |
2011 |
World J. Gastroenterol. |
pmid:22046084
|
Chen SJ et al. |
Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients. |
2008 |
World J. Gastroenterol. |
pmid:18350632
|
Sargýn M et al. |
Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori. |
2003 |
World J. Gastroenterol. |
pmid:12717872
|
O'Morain C |
Role of Helicobacter pylori in functional dyspepsia. |
2006 |
World J. Gastroenterol. |
pmid:16718752
|
Sugimoto M and Furuta T |
Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype. |
2014 |
World J. Gastroenterol. |
pmid:24914361
|
Wu IT et al. |
Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan. |
2015 |
World J. Gastroenterol. |
pmid:26457027
|
Yilmaz O and Demiray E |
Clinical role and importance of fluorescence in situ hybridization method in diagnosis of H pylori infection and determination of clarithromycin resistance in H pylori eradication therapy. |
2007 |
World J. Gastroenterol. |
pmid:17278188
|
Onyekwere CA et al. |
Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: report of an efficacy study. |
2014 |
World J. Gastroenterol. |
pmid:24707145
|
Wu JY et al. |
Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests. |
2014 |
World J. Gastroenterol. |
pmid:24695835
|
Mabe K et al. |
Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer? |
2009 |
World J. Gastroenterol. |
pmid:19750572
|
Riquelme A et al. |
Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile. |
2007 |
World J. Gastroenterol. |
pmid:17589948
|
Ersoy O et al. |
H pylori infection in patients with Behcet's disease. |
2007 |
World J. Gastroenterol. |
pmid:17589951
|